article thumbnail

Aseptic packaging market to value $35bn by 2033

European Pharmaceutical Review

According to a report by Research Nester, the global aseptic packaging market is projected to reach a revenue of $35 billion by 2033 and is estimated to reach a compound annual growth rate (CAGR) of 10 percent between 2023 and 2033. The post Aseptic packaging market to value $35bn by 2033 appeared first on European Pharmaceutical Review.

Packaging 105
article thumbnail

Generics propelling pharmaceutical parenteral packaging market

European Pharmaceutical Review

Research on the global pharmaceutical parenteral packaging market by InsightAce Analytic Pvt. Regionally, North America is anticipated to hold a major portion of the pharmaceutical parenteral packaging market, according to the report. has predicted that the sector will value $18.85 billion by 2031. This is aligned with a CAGR of 4.47

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

CanSinoBIO developed a highly effective COVID vaccine with an inhalant version

pharmaphorum

MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single dose SARS-CoV-2 vaccine offered as an injectable and inhalant that allows ease of storage, an alternative option for individuals with needle phobias, and robust elongated CD4 and CD8 cellular response. Morgon, PharmD, LL.M, How it works. Regarding the BA.4

Vaccines 138
article thumbnail

Bomb scare sparks evacuation of plant making AZ COVID-19 vaccine

pharmaphorum

A plant in Wales manufacturing the AstraZeneca COVID-19 vaccine was evacuated on the advice of the authorities today after it was sent a suspicious package. Wockhardt UK in Wrexham this morning received a suspicious package. Wockhardt UK in Wrexham this morning received a suspicious package.

article thumbnail

IMA: the all-in-one solutions provider for complete vaccines lines

European Pharmaceutical Review

Even with extremely rapid vaccine development, limitations in production capabilities can have real-life implications. To cope with the growing demand for production flexibility and agility, IMA Group is structured according to highly specialised pharmaceutical divisions that concentrate on specific processing and packaging areas.

Vaccines 104
article thumbnail

Moderna unveils $500m plan for African vaccine facility

pharmaphorum

Moderna has said it plans to invest $500 million in a new facility for manufacturing mRNA vaccines in Africa, and has kicked off a search to find a suitable country and location. of Africans have been fully vaccinated against COVID-19, and just 15 African nations have met the agency’s objective of 10% coverage.

article thumbnail

STAT+: Pharmalittle: We’re reading about AstraZeneca threatening the U.K., mpox vaccine distribution, and more

STAT

The comments came in response to an article  The Financial Times  that claimed the company is considered changing the location of a $578 million vaccine manufacturing plant from Liverpool to Philadelphia because the new U.K. million people have had Bavarian Nordic’s vaccine in the U.S.

Vaccines 102